tadalafil has been researched along with Aging in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, N; Blair, HC; Gera, S; Gumerova, A; Hadelia, E; Haider, S; Ievleva, K; Iqbal, J; Kim, SM; Korkmaz, F; Kuo, TC; Li, W; Liu, L; Liu, P; Lizneva, D; Mathew, M; Miyashita, H; New, MI; Perez-Pena, H; Ryu, V; Sant, D; Stanley, S; Sun, L; Tamler, R; Taneja, C; Tourkova, I; Yuen, T; Zaidi, M; Zhu, LL | 1 |
| Alexandre, EC; Antunes, E; Bertollotto, GM; Calmasini, FB; de Oliveira, MG; Jacintho, FF; Justo, AFO; Mónica, FZ | 1 |
| Akita, C; Hirono, K; Ichida, F; Ishida, K; Kohno, H; Nakamura, T; Ozawa, S; Taguchi, M; Yoshimura, N | 1 |
| Al-Amin, MM; Alam, MA; Alam, T; Didar, RR; Hasan, AT; Hasan, SM; Hossain, I; Rahman, MM | 1 |
| Helfand, BT; Mazur, DJ; McVary, KT | 1 |
| Kotb, K; Mostafa, T; Rashed, L; Taymour, M | 1 |
| Frajese, G; Frajese, GV; Pozzi, F | 1 |
2 review(s) available for tadalafil and Aging
| Article | Year |
|---|---|
Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Carbolines; Disease Progression; Erectile Dysfunction; Humans; Imidazoles; Lower Urinary Tract Symptoms; Male; Men's Health; Middle Aged; Neurotransmitter Agents; Piperazines; Prognosis; Prostatic Hyperplasia; Purines; Receptors, Neurotransmitter; Risk Assessment; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2012 |
Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence.
Topics: Adult; Aged; Aged, 80 and over; Aging; Carbolines; Erectile Dysfunction; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Sexual Behavior; Tadalafil | 2006 |
5 other study(ies) available for tadalafil and Aging
| Article | Year |
|---|---|
Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.
Topics: Aging; Animals; Bone and Bones; Bone Density; Brain; Cell Differentiation; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Repositioning; Erectile Dysfunction; Humans; Male; Mice; Middle Aged; Models, Animal; Models, Molecular; Neurons; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporotic Fractures; Phosphodiesterase 5 Inhibitors; Primary Cell Culture; Tadalafil; Vardenafil Dihydrochloride | 2020 |
Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Topics: Acetylcholine; Aging; Animals; Benzoates; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Iliac Artery; Male; Nitric Oxide; Nitroprusside; Pyrazoles; Pyridines; Rats, Wistar; Reactive Oxygen Species; Soluble Guanylyl Cyclase; Tadalafil; Vasodilation; Vasodilator Agents | 2021 |
Plasma concentrations of tadalafil in children with pulmonary arterial hypertension.
Topics: Adolescent; Aging; Antihypertensive Agents; Bosentan; Carbolines; Child; Child, Preschool; Female; Humans; Hypertension, Pulmonary; Infant; Male; Sulfonamides; Tadalafil; Vasodilator Agents | 2014 |
Tadalafil enhances working memory, and reduces hippocampal oxidative stress in both young and aged mice.
Topics: Aging; Animals; Antioxidants; Carbolines; Cyclic GMP; Hippocampus; Male; Maze Learning; Memory, Short-Term; Mice; Motor Activity; Nitric Oxide; Nootropic Agents; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Tadalafil | 2014 |
Effect of testosterone and frequent low-dose sildenafil/tadalafil on cavernous tissue oxidative stress of aged diabetic rats.
Topics: Aging; Animals; Carbolines; Cyclic GMP; Diabetes Mellitus, Experimental; Erectile Dysfunction; Glutathione Peroxidase; Male; Malondialdehyde; Oxidative Stress; Penile Erection; Penis; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Tadalafil; Testosterone; Vasodilator Agents | 2012 |